Whalen Matthew Pratt
Reporting Owner SEC Filing List
CIK: 0002033867
| Form | Filer | Subject Company | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Telomir Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 07/27/2026 | |||
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | 07/27/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Mira Pharmaceuticals, Inc. | 06/15/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | 06/15/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Telomir Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 05/22/2026 | |||
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | 05/22/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Whalen Matthew Pratt | M2 Compliance Llc /fa | 12/10/2024 | |||
| 4 | Statement of changes in beneficial owner... | Mira Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 12/10/2024 | |||
| 3 | Initial statement of beneficial ownershi... | Mira Pharmaceuticals, Inc. | M2 Compliance Llc /fa | 11/26/2024 | |||
| 3 | Initial statement of beneficial ownershi... | Whalen Matthew Pratt | M2 Compliance Llc /fa | 11/26/2024 | |||
| Load More | |||||||
Whalen Matthew Pratt 's Ownership Transactions
| Issuer | Filing Date |
Transaction Date |
Transaction Type |
Shares | Price | Total Amt | Shares Owned |
|---|
